Man Group has got off to a flyer this morning helping the FTSE 100 benchmark to an early gain of about 15 points to 4,599 points.
Man is trading up 25p at 1,302p. Shire Pharmaceuticals is up 19p to 540.75p. The U.K.'s third-largest drugmaker said the US Food and Drug Administration approved its Fosrenol treatment for kidney-failure patients with estimated sales of $200m. Companies performing poorly include British Sky Broadcasting, down 4.25p to 491.25p. Centrica is down 2.25p to 236p. Japanese stocks rose earlier this morning, led by financial companies including Resona and Shinsei Bank after report first-half profits were ahead of forecasts. Tokyo's Nikkei 225 index added 0.2% to 10,691.95 points. Orix...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
